UBS Maintains Buy on Steris, Lowers Price Target to $270

Benzinga Newsdesk www.benzinga.com Negative 73.0%

Neg 73% Neu 0% Pos 0%

UBS analyst Patrick Wood maintains Steris (NYSE:STE) with a Buy and lowers the price target from $275 to $270.

Comments

No comments yet. Be the first!